epi-2021-0277 - The prognostic role of miR-31 in colorectal cancer: the results of a meta-analysis of 4720 patients

Supplementary figure 1 (Fig. S1): Funnel plots and p values of Egger`s and Begg`s bias tests for [i]: overall survival (OS) and [ii]: progression-free survival (PFS). Supplementary figure 2 (Fig. S2): Sensitivity plots for [i]: overall survival (OS) and [ii]: progression-free survival (PFS). Supplementary table 1 (Table S1): Search strategy and the combination keywords used for the systematic search. Supplementary table 2 (Table S2): Quality assessment of the included studies based on the Newcastle-Ottawa Scale (NOS). Supplementary table 3 (Table S3): The relationship of miR-31 expression with tumor location and KRAS/BRAF mutational status.补充图1（图S1）：用于[ⅰ]总生存期（overall survival, OS）及[ⅱ]无进展生存期（progression-free survival, PFS）的Egger偏倚检验、Begg偏倚检验的漏斗图及p值。补充图2（图S2）：针对[ⅰ]总生存期（OS）及[ⅱ]无进展生存期（PFS）的敏感性分析图。补充表1（表S1）：系统检索所采用的检索策略及组合关键词。补充表2（表S2）：基于纽卡斯尔-渥太华量表（Newcastle-Ottawa Scale, NOS）对纳入研究开展的质量评价。补充表3（表S3）：miR-31表达水平与肿瘤部位及KRAS/BRAF突变状态的关联关系。